Anti-Glomerular Basement Membrane Disease

Anti-glomerular basement membrane disease (anti-GBM) is a rare but well-characterized cause of glomerulonephritis. It is defined by the presence of autoantibodies directed at specific antigenic targets within the glomerular and/or pulmonary basement membrane. These antibodies bind to the α3 chain

[1]  R. Kalluri,et al.  COL4A5 gene deletion and production of post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. , 1994, Kidney international.

[2]  E. Goodpasture.  THE SIGNIFICANCE OF CERTAIN PULMONARY LESIONS IN RELATION TO THE ETIOLOGY OF INFLUENZA , 1919 .

[3]  C. Wilson,et al.  Plasma exchange in Goodpasture's syndrome. , 1982, American journal of nephrology.

[4]  J. Grünfeld,et al.  Anti-GBM disease: predictive value of clinical, histological and serological data. , 1993, Clinical nephrology.

[5]  E. Ritz,et al.  Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course. , 1991, Nephron.

[6]  D. Jayne,et al.  Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis. , 1990, Kidney international.

[7]  K. Andrassy,et al.  Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis. , 1992, Journal of the American Society of Nephrology : JASN.

[8]  M. Gubler,et al.  Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation. , 1998, Kidney international.

[9]  K. Kohri,et al.  Glomerular-basement-membrane antibody and extracorporeal shock wave lithotripsy , 1993, The Lancet.

[10]  R. Glassock,et al.  IgA antibasement membrane nephritis with pulmonary hemorrhage. , 1979, Annals of internal medicine.

[11]  L. Revert,et al.  Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. , 1991, Clinical nephrology.

[12]  H. Rammensee,et al.  Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen. , 1996, Kidney international.

[13]  J. Squifflet,et al.  OUTCOME OF THIRTY PATIENTS WITH ALPORT'S SYNDROME AFTER RENAL TRANSPLANTATION , 1991, Transplantation.

[14]  R. Anderson,et al.  Chronic recurrent Goodpasture's syndrome. , 1987, The American journal of medicine.

[15]  C. Winearls,et al.  Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange. , 1984, Clinical nephrology.

[16]  A. Miettinen,et al.  Transformation of membranous glomerulonephritis into crescentic glomerulonephritis with glomerular basement membrane antibodies. Serial determinations of anti-GBM before the transformation. , 1984, Nephron.

[17]  P. Doolan,et al.  GOODPASTURE'S SYNDROME: A CLINICOPATHOLOGIC ENTITY. , 1964, The American journal of medicine.

[18]  N. Rothfield,et al.  A mini-epidemic of Goodpasture's syndrome clinical and immunological studies. , 1974, Nephron.

[19]  J. Cameron,et al.  Intraglomerular T cells and monocytes in nephritis: study with monoclonal antibodies. , 1987, Kidney international.

[20]  C. Wilson,et al.  Goodpasture syndrome: recovery after severe renal insufficiency. , 1976, Archives of internal medicine.

[21]  C. Wilson,et al.  Anti-glomerular basement membrane antibody-induced glomerulonephritis. , 1973, Kidney international.

[22]  C. Unger,et al.  Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease. , 1999, Kidney international.

[23]  C. Pusey,et al.  Recombinant α‐chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition , 1998, Clinical and experimental immunology.

[24]  R. Butkowski,et al.  Specificity of kidney-bound antibodies in Goodpasture's syndrome. , 1989, Clinical and experimental immunology.

[25]  S. Zimmerman,et al.  IDIOPATHIC CRESCENTIC GLOMERULONEPHRITIS , 1977, Medicine.

[26]  N. Rothfield,et al.  A Mini-Epidemic of Goodpasture’s Syndrome , 1974 .

[27]  R. Scully,et al.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. , 1976, The New England journal of medicine.

[28]  R. Lerner,et al.  THE ROLE OF ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY IN THE PATHOGENESIS OF HUMAN GLOMERULONEPHRITIS , 1967, The Journal of experimental medicine.

[29]  G. Bombassei,et al.  The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture's syndrome). , 1992, American journal of industrial medicine.

[30]  A. Rees,et al.  Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. , 1986, British medical journal.

[31]  R. Lechler,et al.  Analysis of T cell responses to the autoantigen in Goodpasture's disease , 1995, Clinical and experimental immunology.

[32]  Moorthy Av,et al.  Association of crescentic glomerulonephritis with membranous glomerulonephropathy: a report of three cases. , 1976 .

[33]  O. Pullig,et al.  Course and prognosis of anti-basement membrane antibody (anti-BM-Ab)-mediated disease: report of 35 cases. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  G. Becker,et al.  Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome. , 1985, The Quarterly journal of medicine.

[35]  A. Maxwell,et al.  Reversal of renal failure in nephritis associated with antibody to glomerular basement membrane. , 1988, BMJ.

[36]  V. Schuster,et al.  Coexistent Wegener's granulomatosis and anti-glomerular basement membrane disease. , 1987, Human pathology.

[37]  A. Rees,et al.  Direct Identification of Naturally Processed Autoantigen-derived Peptides Bound to HLA-DR15* , 1996, The Journal of Biological Chemistry.

[38]  P. Bygren,et al.  Circulating autoantibodies in patients with extracapillary glomerulonephritis. , 1991, Nephrology, Dialysis and Transplantation.

[39]  R. Bear,et al.  Recurrent Goodpasture's syndrome. , 1983, Canadian Medical Association journal.

[40]  K. Tryggvason,et al.  COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. , 1994, Journal of the American Society of Nephrology : JASN.

[41]  R. Kalluri,et al.  The Goodpasture Autoantigen , 1996, The Journal of Biological Chemistry.

[42]  C. Wilson,et al.  Antiglomerular Basement Membrane Antibody‐Mediated Glomerulonephritis and Goodpasture's Syndrome , 1979, Medicine.

[43]  D. Williams,et al.  Recurrent Goodpasture's syndrome. , 1978, Mayo Clinic proceedings.

[44]  R. Steiner,et al.  The chest X-ray in pulmonary capillary haemorrhage: correlation with carbon monoxide uptake. , 1979, Clinical radiology.

[45]  C. Savage,et al.  CLINICAL AND IMMUNOLOGICAL EVOLUTION OF OLIGOANURIC ANTI-GBM NEPHRITIS TREATED BY HAEMODIALYSIS , 1986, The Lancet.

[46]  C. Wilson,et al.  Therapy of Anti‐Glomerular Basement Membrane Antibody Disease: Analysis of Prognostic Significance of Clinical, Pathologic and Treatment Factors , 1985, Medicine.

[47]  C. J. Mcallister,et al.  Rapidly progressive glomerulonephritis. Combined antiglomerular basement membrane antibody and immune complex pathogenesis. , 1981, Human pathology.

[48]  R. Butkowski,et al.  Antigen restriction and IgG subclasses among anti-GBM autoantibodies. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[49]  R. Loertscher,et al.  Anti-glomerular basement membrane glomerulonephritis after extracorporeal shock wave lithotripsy. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[50]  E. Osserman,et al.  IgA heavy chain disease. A case detected in the western hemisphere. , 1975, The American journal of medicine.

[51]  S. Zimmerman,et al.  Association of crescentic glomerulonephritis with membranous glomerulonephropathy: a report of three cases. , 1976, Clinical nephrology.

[52]  R. Lachmann,et al.  Recurrent Goodpasture's disease. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  K. Netzer,et al.  Goodpasture syndrome and end-stage renal failure--to transplant or not to transplant? , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[54]  J. Klassen,et al.  Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis. , 1974, The New England journal of medicine.

[55]  F. Valderrábano,et al.  Report on management of renale failure in Europe, XXVI, 1995. The child-adult interface: a report on Alport's syndrome, 1975-1993. The ERA-EDTA Registry. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[56]  D. Droz,et al.  Linear glomerular IgG fixation in renal allografts: incidence and significance in Alport's syndrome. , 1986, Clinical nephrology.

[57]  G. Becker,et al.  Clinical and Morphological Aspects of the Managment of Crescentic Anti-glomerular Basement Membrane Antibody (Anti-GBM) Nephritis/Goodpasture's Syndrome , 1985 .

[58]  P. Herdson,et al.  Goodpasture's syndrome: an analysis of 29 cases. , 1978, Kidney international.

[59]  A. Rees,et al.  The HLA complex in Goodpasture's disease: a model for analyzing susceptibility to autoimmunity. , 1999, Kidney international.

[60]  C. Rhodes,et al.  Detection of intrapulmonary hemorrhage with carbon monoxide uptake. Application in goodpasture's syndrome. , 1976, The New England journal of medicine.

[61]  W. Couser.  Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[62]  M. Donaghy,et al.  CIGARETTE SMOKING AND LUNG HAEMORRHAGE IN GLOMERULONEPHRITIS CAUSED BY AUTOANTIBODIES TO GLOMERULAR BASEMENT MEMBRANE , 1983, The Lancet.

[63]  R. Schrier,et al.  Serious pulmonary hemorrhage, glomerulonephritis, and massive steroid therapy. , 1975, Annals of internal medicine.

[64]  M. Coughlan,et al.  Presentation of the Goodpasture Autoantigen to CD4 T Cells Is Influenced More by Processing Constraints Than by HLA Class II Peptide Binding Preferences* , 1998, The Journal of Biological Chemistry.